Serina Therapeutics expands equity incentive plan

Serina Therapeutics, Inc., a pharmaceutical company based in Huntsville, Alabama, with a market capitalization of $66.5 billion, announced on Wednesday the expansion of its Equity Incentive Plan following approval from its shareholders. According to InvestingPro data, the company maintains a strong financial health score, rated as "GOOD" by analysts. The amendment to the plan was ratified during the company's Annual Meeting held on Sunday, December 13, 2024.

The approved changes include an increase in the number of shares reserved for issuance under the plan by 950,000 shares, bringing the total to 2,675,000 shares. Furthermore, an automatic annual increase of 5% of the outstanding common stock on the last day of the preceding fiscal year will be applied, starting with the 2026 fiscal year and ending with the first day of the 2034 fiscal year.

During the Annual Meeting, shareholders also voted on several key proposals. The election of directors resulted in Balkrishan "Simba" Gill, Remy Gross, and Steven Mintz being elected to serve until the 2027 Annual Meeting of Stockholders. Additionally, the appointment of Frazier & Deeter, LLC as the company's independent registered public accounting firm for the 2024 fiscal year was ratified.

This expansion of the Equity Incentive Plan is detailed in the "2024 Incentive Plan Amendment Proposal" section of the company's Definitive Proxy Statement, which was filed with the United States Securities and Exchange Commission on November 6, 2024.

The company's stock is traded on the NYSE American under the ticker symbol SERN, and has demonstrated remarkable performance with a 185.9% year-to-date return. InvestingPro analysis reveals several promising indicators, including strong liquidity and positive earnings growth expectations. Subscribers can access 14 additional exclusive ProTips and a comprehensive Pro Research Report for deeper insights into SERN's financial outlook.

In other recent news, Sea Ltd (NYSE:SE) has been under the spotlight with several analyst adjustments following robust third-quarter earnings. Morgan Stanley (NYSE:MS) reiterated its Overweight rating on Sea Ltd, with a price target of $140, highlighting the company's digital entertainment segment's strong performance, particularly Free Fire, which saw a 36% year-over-year revenue increase. The firm also noted Sea Ltd's overall revenue increase of 20.06% over the last twelve months.

Phillip Securities downgraded Sea Ltd's stock rating from Neutral to Reduce, despite raising the fiscal year 2024 earnings and revenue forecasts by 4% and 1% respectively. This revision was attributed to stronger-than-expected growth in two of Sea Ltd's segments, Shopee and SeaMoney. Despite this, analysts at Phillip Securities see limited upside potential in the share price relative to market expectations.

TD Cowen, Morgan Stanley, and Barclays (LON:BARC) all raised their price targets for Sea Ltd following the company's strong performance. The company's digital entertainment arm Garena and its Shopee platform both outperformed expectations, contributing to the revenue increase. The company's digital financial services business also displayed significant growth, with revenue growth jumping from 21% in the second quarter to 38% in the third quarter.

Barclays updated its outlook on Sea Ltd by raising the price target to $131 from the previous $94 while maintaining an Overweight rating. The adjustment followed Sea Ltd's third-quarter performance, which surpassed expectations, particularly in its e-commerce and gaming segments. The firm anticipates that the competitive landscape in Southeast Asia's e-commerce industry will remain stable and that Shopee's Gross Merchandise Volume growth will continue to be robust with expanding margins.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.